LDJ Cayman Fund Ltd. Announces Investment in WePower, Green Energy ICO Innovator
Jan 30, 2018 21:05 pm UTC| Business
WePower Operates Blockchain-Based Green Energy Trading Platform NEW YORK, NY, Jan. 30, 2018 -- LDJ Cayman Fund Ltd., an investment fund focused on crypto asset investments, today announced that it has completed a...
Zillow Group to Attend the Goldman Sachs 2018 Technology & Internet Conference
Jan 30, 2018 21:05 pm UTC| Business
SEATTLE, Jan. 30, 2018 -- Zillow Group, Inc. (NASDAQ:Z) (NASDAQ:ZG), which houses a portfolio of the largest and most vibrant real estate and home-related brands on mobile and the web, today announced that Chief...
New York Mortgage Trust Announces Tax Treatment of 2017 Dividend Distributions
Jan 30, 2018 21:04 pm UTC| Business
NEW YORK, Jan. 30, 2018 -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (“NYMT” or the “Company”) today announced the following tax treatment of common and preferred stock dividends declared in 2017. This information is...
Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology
Jan 30, 2018 21:03 pm UTC| Business
SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today announced the State Intellectual Property...
Datawatch Acquires Data Science Platform Leader Angoss Software
Jan 30, 2018 21:01 pm UTC| Business
BEDFORD, Mass., Jan. 30, 2018 -- Datawatch Corporation (NASDAQ:DWCH), the data intelligence provider with market leading enterprise data preparation, predictive analytics, and visualization solutions, today announced...
Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility
Jan 30, 2018 21:01 pm UTC| Business
SANTA BARBARA, Calif., Jan. 30, 2018 -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for a site-change to...
Jan 30, 2018 21:01 pm UTC| Business
BOSTON, Jan. 30, 2018 -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases,...